Nov 06, 2018
Global Bladder Cancer Market and Competitive Landscape Report 2018
Nov 01, 2018
The Journal of Urology Publishes Valencia's Excellent Feasibility Data on eCoin(TM) for Overactive Bladder
Oct 16, 2018
Triple W Launches DFree, First Wearable Device for Incontinence
Aug 28, 2018
Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder
Aug 08, 2018
Women's Excellence in Bladder Control Now Offers Treatment Plans for Women With Urinary Retention
Jul 24, 2018
Nucleix Announces Publication of Non-Invasive Bladder Cancer Recurrence Detection Study Showing Best-in-Class Performance
Jul 16, 2018
A Connected Wearable Device To Predict Toilet Timing Officially Available in US
Jul 13, 2018
European Outlook on the Overactive Bladder Market 2017-2018 to 2026
Jun 14, 2018
BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim(TM) Implantable Tibial Nerve Neuromodulator for Overactive Bladder
Jun 07, 2018
Mictoryl® Pediatric (propiverine hydrochloride) now covered by several public drug plans to treat symptoms associated with overactive bladder
May 20, 2018
Women's Health and Urinary Functions
Apr 25, 2018
Something fishy: Mexico nabs traveler with endangered totoaba
Apr 24, 2018
Urovant Sciences Strengthens Executive Management Team with Senior Hires and Establishes U.S. Headquarters in Irvine, California
Apr 23, 2018
LABORIE Medical Technologies and Cogentix Medical Announce Completion of Acquisition of Cogentix Medical by LABORIE Medical Technologies
Apr 06, 2018
Global Drugs for Urinary Incontinence and Overactive Bladder Markets to 2022: Focus on Idiopathic Bladder Overactivity, and Neurogenic Bladder Overactivity
Mar 28, 2018
Urovant Sciences Initiates Phase 3 Clinical Program for Vibegron in Patients with Overactive Bladder
Mar 26, 2018
Leading European Bladder Cancer Experts: The Bladder EpiCheck Urine Test Can Reduce Invasive Procedures
Mar 14, 2018
Nucleix Announces its Bladder EpiCheck(TM) Availability on the QIAGEN Rotor-Gene Q Platform
Mar 12, 2018
LABORIE Medical Technologies to acquire Cogentix Medical Inc., for $214 million
Mar 09, 2018
FDA Approves Pivotal Clinical Trial for Technology to Treat Overactive Bladder